Rates of guideline adherence among us community oncologists treating NSCLC

American Journal of Managed Care

Volumn 19, Issue 3, 2013, Pages 185-192

  Wang, Zhaohui ^a   Aksamit, Inga ^a   Tuscher, Lisa ^a   Bergstrom, Kim ^a  

^a McKesson   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER SCREENING; DATA BASE; DISEASE SEVERITY; FOLLOW UP; HEALTH CARE COST; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; METASTASIS; PATIENT COMPLIANCE; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REIMBURSEMENT; RETROSPECTIVE STUDY; UNITED STATES;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DRUG COSTS; GUIDELINE ADHERENCE; HUMANS; LUNG NEOPLASMS; MEDICAL ONCOLOGY; PACLITAXEL; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84877784034     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics [published correction appears in CA Cancer J Clin. 2011;61(2):134]. CA Cancer J Clin. 2011;61(2):69-90.
2. American Cancer Society. Non-small cell lung cancer. Learn About Cancer. http://www.cancer.org/Cancer/LungCancer-Non-SmallCell/index?ssSourceSiteId=null. Published 2011. Accessed July 3, 2011.
3. National Cancer Institute. SEER stat fact sheets: lung and bronchus. Surveillance Epidemiology and End Results (SEER). http://seer.cancer.gov/ statfact/html/lungb.html. Published 2011. Accessed July 2, 2011.
4. Greene FL, Page DL, Fleming ID, et al, eds. Lung. In: AJCC Cancer Staging Manual. Vol 1. 6th ed. Chicago, IL: American Joint Commission on Cancer; 2002:167-177.
5. National Comprehensive Cancer Network. Non-small cell lung cancer. Version 2. Clinical Practice Guidelines in Oncology. http://www.nccn.org. Published 2010. Accessed January 6, 2010.
6. Azzoli CG, Baker S Jr, Temin S, et al American Society of Clinical Oncology. American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol. 2009;27(36):6251-6266.
7. Pisters KM, Evans WK, Azzoli CG, et al Cancer Care Ontario; American Society of Clinical Oncology. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. J Clin Oncol. 2007;25(34):5506-5518. (Pubitemid 350232227)
8. McKesson Specialty Health. Treatment guidelines - non small cell lung cancer. Version 1. McKesson Specialty Care Solutions Treatment Guidelines. http://www.onmarkservices.com. Published 2010. Accessed January 10, 2011.
9. Schrump DS, Altorki NK, Henschke CL, Carter D, Turrisi AT, Gutierrez ME. Lung cancer: non-small cell lung cancer. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology. Vol 1. 7th ed. Philadelphia, PA: Wolters Kluwer Health: Lippincott Williams & Wilkins; 2005:753-809.
10. Hanna N. Adjuvant systemic therapy in resectable non-small cell lung cancer. 19.2. UpToDate. http://www.uptodate.com. Published 2011. Accessed July 8, 2011.
11. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ. 1995;311(7010):899-909.
12. Cufer T, Ovcaricek T, O'Brien ME. Systemic therapy of advanced non-small cell lung cancer: major-developments of the last 5-years [published online December 19, 2012]. Eur J Cancer. pii: S0959-8049(12)00917-3. doi: 10.1016/j.ejca.2012.11.021.
13. Midthun D. Overview of the initial evaluation, treatment and prognosis of lung cancer. 19.2. UpToDate. http://www.uptodate.com. Published 2011. Accessed May 15, 2011.
14. Wöckel A, Kurzeder C, Geyer V, et al. Effects of guideline adherence in primary breast cancer-a 5-year multi-center cohort study of 3976 patients. Breast. 2010;19(2):120-127.
15. Malin JL, Schneider EC, Epstein AM, Adams J, Emanuel EJ, Kahn KL. Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States? J Clin Oncol. 2006;24(4):626-634. (Pubitemid 46630426)
16. Varga D, Wischnewsky M, Atassi Z, et al. Does guideline-adherent therapy improve the outcome for early-onset breast cancer patients? Oncology. 2010;78(3-4):189-195.
17. Ganguli A, Wiegand P, Gao X, Carter JA, Botteman MF, Ray S. The impact of second-line agents on patients' health-related quality of life in the treatment for non-small cell lung cancer: a systematic review [published online July 18, 2012]. Qual Life Res.
18. Tanvetyanon T, Soares HP, Djulbegovic B, Jacobsen PB, Bepler G. A systematic review of quality of life associated with standard chemotherapy regimens for advanced nonsmall cell lung cancer. J Thorac Oncol. 2007;2(12):1091-1097. (Pubitemid 350307901)
19. GraphPad QuickCalcs [computer program]. La Jolla, CA: GraphPad Software; 2011. http://www.graphpad.com. Accessed April 10, 2011.
20. MedCalc [computer program]. Version 12.2.0.0. Mariakerke, Belgium: MedCalc Software; 2011.
21. Ellis PG. Challenge of reducing disease-specific variation in care. Presented at: 2010 ASCO Annual Meeting; June 4-8, 2010; Chicago, IL.
22. Bergstrom KA, Wang Z, Aksamit I, et al. Guideline adherence rates of chemotherapy treatment for breast cancer patients treated in U.S. community oncology practices. J Clin Oncol. 2010;28(15S):abstr 596. http://www.asco.org/ ASCOv2/Meetings/Abstracts?&vmview=abst-detail-view&confID= 74&abstractID=54593. Accessed January 30, 2013.
23. Wang Z, Bergstrom KA, Aksamit I, et al. Guideline adherence rates of chemotherapy treatment for colon cancer patients treated in U.S. community oncology practices. J Clin Oncol. 2010;28(15S):abstr 3620. http://www.asco.org/ ASCOv2/Meetings/Abstracts?&vmview=abst-detail-view&confID= 74&abstractID=54357. Accessed January 30, 2013.
24. Lilenbaum R. Initial systemic chemotherapy for advanced nonsmall cell lung cancer. 19.1. UpToDate. http://www.uptodate.com. Published 2011. Accessed April 4, 2011.
25. Bergstrom KA. Management of unresectable locoregionally advanced and metastatic nonsquamous NSCLC. Am J Pharm Benefits. 2011;3(2):89-93.
26. Neubauer MA, Hoverman JR, Kolodziej M, et al. Cost effectiveness of evidence-based treatment guidelines for the treatment of nonsmall- cell lung cancer in the community setting. J Oncol Pract. 2010;6(1):12-18.
27. Eldridge L. Lung cancer: lung cancer survival rates by type and stage. About.com. Lung Cancer. http://lungcancer.about.com/od/ whatislungcancer/a/ lungcancersurvivalrates.htm?p=1. Published 2011. Accessed February 23, 2012.